Hypoxia-Induced Activation of JAK/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia
Overview
Pathology
Authors
Affiliations
BACKGROUND To explore the effect of hypoxic preconditioning on the JAK/STAT3 signaling pathway and its effect on trophoblast cell viability and angiogenesis in preeclampsia (PE). MATERIAL AND METHODS Placental tissues from normal pregnant women and PE patients were collected to detect the expression levels of JAK and STAT3. Trophoblast cells separated from the PE patients were assigned to 4 groups. The expression levels of phosphorylated p-JAK and p-STAT3 were measured by Western blot. Cell viability, colony-forming ability, and cell apoptosis were assessed. The levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF) were determined by enzyme-linked immunosorbent assay (ELISA). RESULTS The expression levels of JAK and STAT3 were higher in the placental tissues of PE patients than in those of normal pregnant women. Compared with the blank group, in the hypoxia group the expression levels of p-JAK and p-STAT3 were increased, cell viability was promoted, the number of colonies was increased, cell apoptosis was inhibited, and the levels of VEGF, bFGF, and HGF were all elevated. However, in comparison with the hypoxia group, the expression levels of p-JAK and p-STAT3 were reduced, the cell viability was inhibited, the colonies were decreased, the levels of VEGF, bFGF, and HGF were all decreased, and cell apoptosis was promoted in the hypoxia + si-JAK group. CONCLUSIONS These findings indicate that hypoxic preconditioning may contribute to activation of the JAK/STAT3 signaling pathway, thus promoting trophoblast cell viability and angiogenesis in PE.
Importance of STAT3 signaling in preeclampsia (Review).
Marzioni D, Piani F, Di Simone N, Giannubilo S, Ciavattini A, Tossetta G Int J Mol Med. 2025; 55(4).
PMID: 39918020 PMC: 11878484. DOI: 10.3892/ijmm.2025.5499.
Bukowska P, Bralewska M, Pietrucha T, Sakowicz A Int J Mol Sci. 2024; 25(22).
PMID: 39596234 PMC: 11594370. DOI: 10.3390/ijms252212167.
Different Proteomic Profiles Regarding Antihypertensive Therapy in Preeclampsia Pregnant.
Pinto-Souza C, Kaihara J, Nunes P, Mastella M, Rossini B, Cavecci-Mendonca B Int J Mol Sci. 2024; 25(16).
PMID: 39201423 PMC: 11354552. DOI: 10.3390/ijms25168738.
Ciani L, Libonati A, Dri M, Pomella S, Campanella V, Barillari G Int J Mol Sci. 2024; 25(10).
PMID: 38791123 PMC: 11121237. DOI: 10.3390/ijms25105083.
Borodina E, Gzgzyan A, Dzhemlikhanova L, Niauri D, Tolibova G, Tral T Clin Exp Immunol. 2023; 213(2):235-242.
PMID: 37243348 PMC: 10361736. DOI: 10.1093/cei/uxad057.